Hans-Georg LerchenManaging Director and Chief Scientific Officer at Vincerx Pharma GmbH, GermanySpeaker
Agenda Sessions
Legumain-cleavable ADCs with Kinesin Spindle Protein Inhibitor Payloads: Tailored Design for Solid Tumors and Heme Malignancies
, 10:35amView Session